Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2009-07-01
2011-12-27
Murray, Jeffrey (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
08084453
ABSTRACT:
Novel substituted indoloquinoxalines of formula (IwhereinR1is hydrogen or represents one or more similar or different substituents in the positions 7 to 10 selected from the group halogen, lower alkyl/alkoxy, hydroxy, trifluoromethyl, trichloromethyl, trifluoromethoxy,R2represents similar or different C1-C4alkyl substituents,X is CO or CH2,Y is OH, NH2, NH—(CH2)n—R3wherein R3represents lower alkyl, OH, NH2, NHR4or NR5R6wherein R4, R5and R6independently are lower alkyl or cyclo-alkyl and n is an integer of from 2 to 4,with the provision that when X is CH2, Y is OH or NH—(CH2)n—OH,and pharmacologically acceptable salts thereof are described.The compounds are useful as drugs for preventing and/or treating autoimmune diseases.
REFERENCES:
patent: 6248742 (2001-06-01), Bergman et al.
patent: 6333327 (2001-12-01), Moller et al.
patent: 1 261 344 (2002-12-01), None
patent: 0160371 (2001-08-01), None
Schiaffino et al, “Assessing Chronic Illness Representations: The Implicit Models of Illness Questionnaire”, Journal of Behavioral Medicine, vol. 18, No. 6. 1995, pp. 531-548.
http://www.msakc.org/Articles/MSPain.htm; last accessed Jun. 20, 2008.
Hendershott, C.H., Processing of the American Society of Horticultural Science, (1964), 85, 201-9.
Zawadoski et al, “Synthesis of some 6-substituted derivatives of indophenazine with potential pharmacological activity”, Acta Poloniae Pharmaceutica, vol. 52, No. 3, pp. 249-251 (1995).
Bergman Jan
Bjorklund Ulf
Engovist Robert
Gerdin Bengt
Kihlstrom Ingemar
Browdy and Neimark PLLC
Murray Jeffrey
Oxypharma AB
LandOfFree
Alkyl substituted indoloquinoxalines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Alkyl substituted indoloquinoxalines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alkyl substituted indoloquinoxalines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4316780